000 04081nam a22003615i 4500
001 234248
003 ES-VaUE
005 20221220020550.0
007 cr nn 008mamaa
008 130109s2013 xxu| s |||| 0|eng d
020 _a9781627032605
024 7 _a10.1007/978-1-62703-260-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
245 1 0 _aSynthetic Messenger RNA and Cell Metabolism Modulation
_bMethods and Protocols
_cedited by Peter M. Rabinovich.
250 _a1st edition 2013
264 1 _aTotowa, NJ
_bHumana Press
_c2013
300 _a1 recurso en línea (XI, 324 páginas)
_b49 ilustraciones, 18 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v969
505 0 _aCell Engineering with Synthetic Messenger RNA -- In vitro Transcription of Long RNA Containing Modified Nucleosides -- HPLC Purification of in vitro Transcribed Long RNA -- Synthetic mRNAs with Superior Translation and Stability Properties -- Non-Viral, Cationic Lipid-Mediated Delivery of mRNA -- Light-Induced mRNA Transfection -- Engineering B Cells with mRNA -- Programming Human Dendritic Cells with mRNA -- Large Volume Flow Electroporation of mRNA: Clinical Scale Process -- Retrovirus-Based mRNA Transfer for Transient Cell Manipulation -- mRNA Delivery to Human Dendritic Cells by Recombinant -- Non-Viral RNA Transfection to Transiently Modify T Cells with Chimeric Antigen Receptors for Adoptive Therapy -- Natural Killer Cell Reprogramming with Chimeric Immune Receptors -- Reprogramming to Pluripotency and Differentiation of Cells with Synthetic mRNA -- Anti-Tumor Vaccination with Synthetic mRNA: Strategies for in vitro and in vivo Preclinical Studies -- Mannosylated and Histidylated LPR Technology for Vaccination with Tumor Antigen mRNA -- Analysis of Surviving-Specific T Cells in Breast Cancer Patients Using Human DCs Engineered with Survivin mRNA -- mRNA electroporation as a Tool for Immunomonitoring -- mRNA PCR-Based Epitope Chase Method.
520 _aSynthetic mRNA is an attractive tool for mammalian cell reprogramming that  can be used in basic research, as well as in clinical applications. Present mRNA in vitro synthesis is a rather simple procedure, which delivers a high yield of quality product. Various modifications may be introduced into the mRNA by changing  the sequence of the DNA template, by modifying the reaction of transcription, or by post-transcriptional modification. mRNA, as a transfection agent, has several advantages over DNA, as mRNA expression is not dependent on nuclear entry and occurs directly in the cytosol. Synthetic Messenger RNA and Cell Metabolism Modulation: Methods and Protocols covers the typical main methods, such as mRNA synthesis, modifications, and delivery.  Examples of cell reprogramming and analysis in the fields of immunotherapy and stem cell research are also included. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Synthetic Messenger RNA and Cell Metabolism Modulation: Methods and Protocols will be of interest to researchers, clinicians, and biotech companies interested in mRNA-mediated cell reprogramming.
700 1 _aRabinovich, Peter M
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9781627032612
776 0 8 _iPrinted edition:
_z9781627032599
776 0 8 _iPrinted edition:
_z9781493959679
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-62703-260-5
_z(usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
988 _aSpringer_Protocols_2013
999 _c234248
_d234248